Financial reports
10-Q
2024 Q2
Quarterly report
9 Aug 24
10-Q
2024 Q1
Quarterly report
26 Jun 24
NT 10-Q
Notice of late quarterly filing
15 May 24
10-K
2023 FY
Annual report
22 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
10-Q
2023 Q3
Quarterly report
16 Jan 24
NT 10-Q
Notice of late quarterly filing
15 Nov 23
10-Q
2023 Q2
Quarterly report
18 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
Current reports
8-K
Amendments to Articles of Incorporation or Bylaws
24 Sep 24
8-K
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
31 Jul 24
8-K
TRxADE Health, Inc. Announces Special Cash Dividend
9 Jul 24
8-K
Departure of Directors or Certain Officers
20 Jun 24
8-K
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
30 May 24
8-K
Other Events
23 May 24
8-K
TRxADE Health, Inc. Announces Special Cash Dividend
6 Mar 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Other Events
17 Jan 24
8-K
Entry into a Material Definitive Agreement
11 Jan 24
Registration and prospectus
1-A
Offering $20.00 mm in Equity
25 Sep 24
425
Business combination disclosure
14 Jul 23
425
Business combination disclosure
30 Jun 23
S-1
IPO registration
18 Apr 23
424B3
Prospectus supplement
8 Dec 22
S-1
IPO registration
28 Nov 22
424B5
Prospectus supplement for primary offering
6 Oct 22
424B5
Prospectus supplement for primary offering
23 Aug 22
S-3
Shelf registration
29 Jul 22
424B5
Prospectus supplement for primary offering
6 Dec 21
Proxies
DEF 14C
Information statement
28 Aug 24
PRE 14C
Preliminary information
15 Aug 24
PRE 14A
Preliminary proxy
17 May 24
PRER14A
Preliminary revised proxy
25 Sep 23
PRER14A
Preliminary revised proxy
8 Sep 23
PRE 14A
Preliminary proxy
14 Aug 23
DEF 14A
Definitive proxy
25 May 23
PRE 14A
Preliminary proxy
8 May 23
DEFA14A
Additional proxy soliciting materials
9 Nov 22
DEF 14A
Definitive proxy
9 Nov 22
Other
SEC STAFF ACTION
SEC staff action: Order
26 Feb 24
EFFECT
Notice of effectiveness
5 Dec 22
UPLOAD
Letter from SEC
30 Nov 22
CORRESP
Correspondence with SEC
30 Nov 22
EFFECT
Notice of effectiveness
9 Aug 22
CORRESP
Correspondence with SEC
4 Aug 22
UPLOAD
Letter from SEC
4 Aug 22
EFFECT
Notice of effectiveness
4 Sep 20
CORRESP
Correspondence with SEC
1 Sep 20
UPLOAD
Letter from SEC
1 Sep 20
Ownership
3
Hariharan Shankar
5 Aug 24
3
Mani Narasimhan
5 Aug 24
4/A
SURENDRA K AJJARAPU
28 May 24
4/A
Prashant Patel
28 May 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Prashant Patel
16 Jan 24
4
SURENDRA K AJJARAPU
16 Jan 24
4
Janet Huffman
24 Feb 23
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 23
4
MICHAEL L PETERSON
20 Jan 23